1. Home
  2. KW vs ANIP Comparison

KW vs ANIP Comparison

Compare KW & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KW
  • ANIP
  • Stock Information
  • Founded
  • KW 1977
  • ANIP 2001
  • Country
  • KW United States
  • ANIP United States
  • Employees
  • KW N/A
  • ANIP N/A
  • Industry
  • KW Real Estate
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • KW Finance
  • ANIP Health Care
  • Exchange
  • KW Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • KW 1.4B
  • ANIP 1.3B
  • IPO Year
  • KW 1992
  • ANIP N/A
  • Fundamental
  • Price
  • KW $6.69
  • ANIP $65.56
  • Analyst Decision
  • KW Hold
  • ANIP Strong Buy
  • Analyst Count
  • KW 1
  • ANIP 8
  • Target Price
  • KW $13.00
  • ANIP $80.13
  • AVG Volume (30 Days)
  • KW 1.1M
  • ANIP 296.7K
  • Earning Date
  • KW 08-06-2025
  • ANIP 08-05-2025
  • Dividend Yield
  • KW 7.13%
  • ANIP N/A
  • EPS Growth
  • KW N/A
  • ANIP N/A
  • EPS
  • KW N/A
  • ANIP N/A
  • Revenue
  • KW $514,600,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • KW $31.15
  • ANIP $30.52
  • Revenue Next Year
  • KW $2.98
  • ANIP $7.40
  • P/E Ratio
  • KW N/A
  • ANIP N/A
  • Revenue Growth
  • KW N/A
  • ANIP 30.27
  • 52 Week Low
  • KW $5.98
  • ANIP $52.50
  • 52 Week High
  • KW $11.88
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • KW 54.18
  • ANIP 60.18
  • Support Level
  • KW $6.48
  • ANIP $62.81
  • Resistance Level
  • KW $6.86
  • ANIP $64.45
  • Average True Range (ATR)
  • KW 0.18
  • ANIP 1.88
  • MACD
  • KW 0.04
  • ANIP 0.71
  • Stochastic Oscillator
  • KW 72.66
  • ANIP 97.37

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: